Ascentage Pharma (06855.HK): Trustee purchases 50,000 shares for the purpose of the 2022 Restricted Share Unit Plan

Zhitong Finance APP News, Ascentage Pharma (06855.HK) announced that on September 28, 2026, the trustee purchased a total of 50,000 existing shares on-market for the purpose of the 2022 Restricted Share Unit Scheme to satisfy Restricted Share Units upon vesting.